Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toyoshi Inoguchi

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Current Drug Targets|July 20, 2005
Diabetes mellitusToyoshi Inoguchi
Nihon Jinzo Gakkai Shi|November 12, 2011
[Role of oxidative stress in pathogenesis of diabetic nephropathy]Toyoshi Inoguchi
Kidney International|July 25, 2018
The Authors ReplyMasakazu Fujii, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Oxidative stress]Yasutaka Maeda, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Pathophysiological role of renin-angiotensin-aldosterone system in the development of diabetic complication]Yasutaka Maeda, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Role of oxidative stress in pathogenesis of diabetic complications]Noriyuki Sonoda, Toyoshi Inoguchi
Diabetes & Metabolism Journal|September 6, 2012
The role of oxidative stress in the pathogenesis of diabetic vascular complicationsShuji Sasaki, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Role of PKC in the pathogenesis of diabetic vascular complications]Toyoshi Inoguchi, Fumio Umeda
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 10, 2008
[Role of oxidative stress in diabetic vascular complications]Toyoshi Inoguchi, Ryoichi Takayanagi
Current Drug Targets|July 20, 2005
NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndromeToyoshi Inoguchi, Hajime Nawata
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Current Drug Targets|July 20, 2005
Diabetes mellitusToyoshi Inoguchi
Nihon Jinzo Gakkai Shi|November 12, 2011
[Role of oxidative stress in pathogenesis of diabetic nephropathy]Toyoshi Inoguchi
Kidney International|July 25, 2018
The Authors ReplyMasakazu Fujii, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 8, 2010
[Oxidative stress]Yasutaka Maeda, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Pathophysiological role of renin-angiotensin-aldosterone system in the development of diabetic complication]Yasutaka Maeda, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Role of oxidative stress in pathogenesis of diabetic complications]Noriyuki Sonoda, Toyoshi Inoguchi
Diabetes & Metabolism Journal|September 6, 2012
The role of oxidative stress in the pathogenesis of diabetic vascular complicationsShuji Sasaki, Toyoshi Inoguchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Role of PKC in the pathogenesis of diabetic vascular complications]Toyoshi Inoguchi, Fumio Umeda
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 10, 2008
[Role of oxidative stress in diabetic vascular complications]Toyoshi Inoguchi, Ryoichi Takayanagi
Current Drug Targets|July 20, 2005
NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndromeToyoshi Inoguchi, Hajime Nawata
Pageof 11